Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 22, 2022 - Issue 4
Submit an article Journal homepage
714
Views
4
CrossRef citations to date
0
Altmetric
Review

Conventional type 1 dendritic cells (cDC1) as cancer therapeutics: challenges and opportunities

Phillip Johnsona Mater Research Institute-The University of Queensland, Translational Research Institute, Brisbane, Australia;b Queensland Cord Blood Bank At The Mater, South Brisbane, AustraliaORCID Iconhttps://orcid.org/0000-0002-4964-8153View further author information
ORCID Icon,
Nikita Rosendahla Mater Research Institute-The University of Queensland, Translational Research Institute, Brisbane, AustraliaORCID Iconhttps://orcid.org/0000-0002-5188-7487View further author information
ORCID Icon &
Kristen J Radforda Mater Research Institute-The University of Queensland, Translational Research Institute, Brisbane, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6512-6323View further author information
ORCID Icon
Pages 465-472 | Received 23 Jul 2021, Accepted 14 Oct 2021, Published online: 26 Oct 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Raquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, Daniel M Borras, Jannes Govaerts, Stefan Naulaerts, Zwi N Berneman, Benoit Beuselinck, Kalijn F Bol, Jannie Borst, an Coosemans, Angeliki Datsi, Jitka Fučíková, Lisa Kinget, Bart Neyns, Gerty Schreibelt, Evelien Smits, Rüdiger V Sorg, Radek Spisek, Kris Thielemans, Sandra Tuyaerts, Steven De Vleeschouwer, I Jolanda M de Vries, Yanling Xiao & Abhishek D Garg. (2022) Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. OncoImmunology 11:1.
Read now

Articles from other publishers (3)

Jean-Pierre Bikorimana, Nehme El-Hachem, Jamilah Abusarah, Nicoletta Eliopoulos, Sebastien Talbot, Riam Shammaa & Moutih Rafei. (2022) The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells. iScience 25:12, pages 105537.
Crossref
María Luisa Sánchez-León, Carlos Jiménez-Cortegana, Gabriel Cabrera, Elba Mónica Vermeulen, Luis de la Cruz-Merino & Victor Sánchez-Margalet. (2022) The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells. Frontiers in Immunology 13.
Crossref
Jean Pierre Bikorimana, Nehme El-Hachem, Jamilah Abusarah, Nicoletta Eliopoulos, Sebastien Talbot, Riam Shammaa & Moutih Rafei. (2022) The <i>CIt</i> Protocol: A Blueprint to Potentiate the Immunogenicity of Immunoproteasome-Reprogrammed Mesenchymal Stromal Cells. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.